SYGNIA ITRIX (RF) PROPRIETARY LIMITED - Index Constituent Change - SYGH

Index Constituent Change - SYGH

SYGNIA ITRIX COLLECTIVE INVESTMENT SCHEME
Sygnia Itrix Solactive Healthcare 150 ETF
JSE Code: SYGH
ISIN: ZAE000300521


A portfolio in the Sygnia Itrix Collective Investment Scheme in
Securities, registered as such in terms of the Collective Investment
Schemes Control Act, 45 of 2002.

INDEX CONSTITUENT CHANGE - SYGH

In terms of section 19.28 of the JSE Limited Listings Requirements,
notice is hereby given to investors of the above ETF securities that
the following changes in the constituents of the underlying index in
the table below is effective from 04 August 2022.

The following constituents have been added to SYGH:

                                             
                 Share                       Previous  New Weight
ISIN                                         Weight
                 HALOZYME THERAPEUTICS INC   0.00%        0.09%
US40637H1095
                 SHIMADZU CORP ORD           0.00%        0.13%
JP3357200009
                 SIEMENS AG                  0.00%        1.19%
DE0007236101

The following constituents have been removed from SYGH:

                                             
                 Share                       Previous     New Weight
ISIN                                         Weight
US88025U1097     10X GENOMICS INC            0.05%        0.00%

CA0717341071     BAUSCH HEALTH COS INC       0.02%        0.00%

US29332G1022     ENHABIT INC                 0.01%        0.00%

FR0014008VX5     EUROAPI SAS                 0.01%        0.00%
US8753722037     TANDEM DIABETES CARE INC    0.06%        0.00%


The above gave affect to changes in the index constituent weights.
The portfolio composition file can be viewed at www.sygnia.co.za/etfs/etf-and-etn-fund-range.

04 August 2022

Manager
Sygnia Itrix (RF) Pty Limited


JSE Sponsor
Vunani

Date: 04-08-2022 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.